They found that methylation of GALR1 promoter region is one of the most common molecular alterations in endometrial cancer, and it predicted the presence of endometrial malignancy with a specificity of 78.9% and a sensitivity of 92.7% [35]. The gene discussed is GALR1; the disease is endometrial cancer.